百
02185
百心安－Ｂ
3.020
-0.130-4.13%Closed16:08 05/29 HKT
OPEN/PREV CLOSE3.150/3.150
TODAY RANGE3.020-3.300
VOL70.00K
MARKET CAP735.12M
52 WEEK RANGE2.450-10.770
AVG VOL (3M)554.34K
% TURNOVER0.03%
TURNOVER216.13K
P/E (TTM)-9.479
% RANGE8.89%
EPS(TTM)-0.319
P/E(FORWARD)-5.215
P/B1.527
BVPS1.978
DIVIDEND--
P/S14.775
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP711.82M
SHARES OUTSTANDING243.42M
NEXT EARNINGS--
FREE FLOAT235.70M
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·01/26 13:12
AngioCare Secures Indonesian Registration for Iberis RDN System
Simply Wall St·01/06 00:53
Individual investors among Shanghai Bio-heart Biological Technology Co., Ltd.'s (HKG:2185) largest shareholders, saw gain in holdings value after stock jumped 14% last week
Reuters·11/26/2025 11:09
Shanghai Bio-heart Wins New Zealand Approval for Iberis RDN System
Reuters·10/30/2025 14:07
Shanghai Bio-heart Wins UK Regulatory Approval for Iberis RDN System
Simply Wall St·09/09/2025 22:25
Shanghai Bio-heart Biological Technology Co., Ltd.'s (HKG:2185) stock price dropped 12% last week; individual investors would not be happy
Reuters·08/26/2025 13:56
SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY H1 CAPEX RMB 200 THOUSAND
Simply Wall St·07/16/2025 22:02
3 Asian Penny Stocks With Market Caps Over US$100M To Consider
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.